Skip to main content
Clinical Trials/ACTRN12624000887572
ACTRN12624000887572
Not yet recruiting
未知

Investigation of Optical Coherence Tomography Angiography (OCTA) as a non-invasive technique to detect early retinal microvascular dysfunction in children with Diabetes Mellitus

ions Eye Institute0 sites401 target enrollmentJuly 22, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
diabetes mellitus
Sponsor
ions Eye Institute
Enrollment
401
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 22, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ions Eye Institute

Eligibility Criteria

Inclusion Criteria

  • Diabetic Participants:
  • Children aged 10\-18 diagnosed with diabetes Type 1 or 2
  • Participant or parent/guardian willing and able to provide informed consent
  • Participant in the Western Australian Children's Diabetes Database
  • grading of no retinopathy per ETDRS classification
  • normal urine and serum kidney biomarkers
  • Healthy Participants:
  • Aged 10\-18
  • Participant or parent/guardian willing and able to provide informed consent
  • Normal visual acuity, retinal images and no history of ocular disease

Exclusion Criteria

  • For both healthy and diabetic participants:
  • 1\.Abnormal results from serum or urine kidney biomarker samples as determined by the study doctor
  • 2\.Presence or history of any clinically significant disease or condition, or taking medications that in the opinion of the investigator may affect participant safety or affect the outcome of the investigation
  • 3\.Participants, who in the opinion of the investigator are not likely to complete the study for whatever reason
  • 4\.For healthy participants only \- abnormal Visual Acuity or retinal colour photography images, history of ocular disease (including refractive error greater than \-2D dioptres of myopia or \+3 dioptres of hyperopia); Abnormal urine kidney biomarkers or HbA1c.

Outcomes

Primary Outcomes

Not specified

Similar Trials